These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 27394932)
21. Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial. Hamilton JD; Nguyen QX; Gerber RM; Rubio NB Am J Addict; 2009; 18(1):48-52. PubMed ID: 19219665 [TBL] [Abstract][Full Text] [Related]
22. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Winhusen T; Somoza E; Ciraulo DA; Harrer JM; Goldsmith RJ; Grabowski J; Coleman FS; Mindrum G; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Horn P; Montgomery MA; Elkashef A Drug Alcohol Depend; 2007 Dec; 91(2-3):141-8. PubMed ID: 17629631 [TBL] [Abstract][Full Text] [Related]
23. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Kosten TR; Domingo CB; Shorter D; Orson F; Green C; Somoza E; Sekerka R; Levin FR; Mariani JJ; Stitzer M; Tompkins DA; Rotrosen J; Thakkar V; Smoak B; Kampman K Drug Alcohol Depend; 2014 Jul; 140():42-7. PubMed ID: 24793366 [TBL] [Abstract][Full Text] [Related]
24. A screening trial of amantadine as a medication for cocaine dependence. Shoptaw S; Kintaudi PC; Charuvastra C; Ling W Drug Alcohol Depend; 2002 May; 66(3):217-24. PubMed ID: 12062456 [TBL] [Abstract][Full Text] [Related]
25. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920 [TBL] [Abstract][Full Text] [Related]
26. Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder. McCann DJ; Chen HH; Devine EG; Gyaw S; Ramey T Drug Alcohol Depend; 2024 Feb; 255():111063. PubMed ID: 38163425 [TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial. Jones HE; Johnson RE; Bigelow GE; Silverman K; Mudric T; Strain EC Am J Addict; 2004; 13(5):421-37. PubMed ID: 15764421 [TBL] [Abstract][Full Text] [Related]
28. The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study. Shorter D; Lindsay JA; Kosten TR Drug Alcohol Depend; 2013 Jul; 131(1-2):66-70. PubMed ID: 23306096 [TBL] [Abstract][Full Text] [Related]
29. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. LaRowe SD; Kalivas PW; Nicholas JS; Randall PK; Mardikian PN; Malcolm RJ Am J Addict; 2013; 22(5):443-52. PubMed ID: 23952889 [TBL] [Abstract][Full Text] [Related]
30. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Schmitz JM; Mooney ME; Moeller FG; Stotts AL; Green C; Grabowski J Drug Alcohol Depend; 2008 Apr; 94(1-3):142-50. PubMed ID: 18164144 [TBL] [Abstract][Full Text] [Related]
31. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials. Kishi T; Matsuda Y; Iwata N; Correll CU J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105 [TBL] [Abstract][Full Text] [Related]
32. Carvedilol does not reduce cocaine use in methadone-maintained cocaine users. Sofuoglu M; Poling J; Babuscio T; Gonsai K; Severino K; Nich C; Carroll KM J Subst Abuse Treat; 2017 Feb; 73():63-69. PubMed ID: 28017186 [TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence. Cornish JW; Maany I; Fudala PJ; Ehrman RN; Robbins SJ; O'Brien CP Drug Alcohol Depend; 2001 Jan; 61(2):183-9. PubMed ID: 11137283 [TBL] [Abstract][Full Text] [Related]
34. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866 [TBL] [Abstract][Full Text] [Related]
35. Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity. Larrimore KE; Barcus M; Kannan L; Gao Y; Zhan CG; Brimijoin S; Mor T Chem Biol Interact; 2013 Mar; 203(1):217-20. PubMed ID: 23000451 [TBL] [Abstract][Full Text] [Related]
36. Participants receiving dehydroepiandrosterone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study. Shoptaw S; Majewska MD; Wilkins J; Twitchell G; Yang X; Ling W Exp Clin Psychopharmacol; 2004 May; 12(2):126-35. PubMed ID: 15122957 [TBL] [Abstract][Full Text] [Related]
37. A pilot trial of topiramate for the treatment of cocaine dependence. Kampman KM; Pettinati H; Lynch KG; Dackis C; Sparkman T; Weigley C; O'Brien CP Drug Alcohol Depend; 2004 Sep; 75(3):233-40. PubMed ID: 15283944 [TBL] [Abstract][Full Text] [Related]
38. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence. Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353 [TBL] [Abstract][Full Text] [Related]